Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 504

1.

Identification of four patients with colistin-resistant Escherichia coli containing the mobile colistin resistance mcr-1 gene from a single health system in Michigan.

Henig O, Rojas LJ, Bachman MA, Rudin SD, Brennan BM, Soehnlen MK, Jones KL, Mills JP, Dombecki CR, Valyko AM, Marshall SH, Bonomo RA, Kaye KS, Washer L.

Infect Control Hosp Epidemiol. 2019 Jul 15:1-4. doi: 10.1017/ice.2019.177. [Epub ahead of print]

PMID:
31303191
2.

Corrigendum to: 1757. Using the Desirability of Outcome Ranking for Management of Antimicrobial Therapy (DOOR-MAT) to Assess Antibiotic Therapy Guided by Rapid Molecular Diagnostics (RMD) in Bloodstream Infection (BSI) Caused by Escherichia coli and Klebsiella pneumonia.

Wilson B, Viau R, Perez F, Jiang H, Fowler VG Jr, Chambers HF, Kreiswirth BN, Bonomo RA, Evans SR; ARLG.

Open Forum Infect Dis. 2019 Jul 3;6(7):ofz267. doi: 10.1093/ofid/ofz267. eCollection 2019 Jul.

3.

Cryo-Electron Microscopy Structure of an Acinetobacter baumannii Multidrug Efflux Pump.

Su CC, Morgan CE, Kambakam S, Rajavel M, Scott H, Huang W, Emerson CC, Taylor DJ, Stewart PL, Bonomo RA, Yu EW.

MBio. 2019 Jul 2;10(4). pii: e01295-19. doi: 10.1128/mBio.01295-19.

4.

Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.

Mojica MF, Rutter JD, Taracila M, Abriata LA, Fouts DE, Papp-Wallace KM, Walsh TJ, LiPuma JJ, Vila AJ, Bonomo RA.

MBio. 2019 Jul 2;10(4). pii: e00405-19. doi: 10.1128/mBio.00405-19.

5.

Structural insights into the inhibition of the extended-spectrum β-lactamase PER-2 by Avibactam.

Ruggiero M, Papp-Wallace KM, Barnes MD, Bonomo RA, Gutkind G, Klinke S, Power P.

Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00487-19. doi: 10.1128/AAC.00487-19. [Epub ahead of print]

PMID:
31235626
6.

The Pitt Bacteremia Score Predicts Mortality in Non-Bacteremic Infections.

Henderson H, Luterbach CL, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, Harris A, Napravnik S, van Duin D.

Clin Infect Dis. 2019 Jun 19. pii: ciz528. doi: 10.1093/cid/ciz528. [Epub ahead of print]

PMID:
31219148
7.

Nacubactam enhances meropenem activity against carbapenem-resistant Klebsiella pneumoniae producing Klebsiella pneumoniae carbapenemases (KPC).

Barnes MD, Taracila MA, Good CE, Bajaksouzian S, Rojas LJ, van Duin D, Kreiswirth BN, Jacobs MR, Haldimann A, Papp-Wallace KM, Bonomo RA.

Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00432-19. doi: 10.1128/AAC.00432-19. [Epub ahead of print]

PMID:
31182530
8.

Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria.

Luna BM, Ershova K, Yan J, Ulhaq A, Nielsen TB, Hsieh S, Pantapalangkoor P, Vanscoy B, Ambrose P, Rudin S, Hujer K, Bonomo RA, Actis L, Skaar EP, Spellberg B.

J Antimicrob Chemother. 2019 Jun 6. pii: dkz225. doi: 10.1093/jac/dkz225. [Epub ahead of print]

PMID:
31170282
9.

Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa.

Papp-Wallace KM, Zeiser ET, Becka SA, Park S, Wilson BM, Winkler ML, D'Souza R, Singh I, Sutton G, Fouts DE, Chen L, Kreiswirth BN, Ellis-Grosse EJ, Drusano GL, Perlin DS, Bonomo RA.

J Infect Dis. 2019 May 17. pii: jiz149. doi: 10.1093/infdis/jiz149. [Epub ahead of print]

PMID:
31099835
10.

Cardiac Devices Enveloped with an Ounce of Prevention.

Perez F, Bonomo RA.

N Engl J Med. 2019 May 16;380(20):1965-1966. doi: 10.1056/NEJMe1905678. No abstract available.

PMID:
31091379
11.

Patient-to-Patient Transmission of Acinetobacter baumannii Gastrointestinal Colonization in the Intensive Care Unit.

Harris AD, Johnson JK, Pineles L, O'Hara LM, Bonomo RA, Thom KA.

Antimicrob Agents Chemother. 2019 May 13. pii: AAC.00392-19. doi: 10.1128/AAC.00392-19. [Epub ahead of print]

PMID:
31085518
12.

Carbapenem-resistant Enterobacteriaceae: global action required.

Perez F, Bonomo RA.

Lancet Infect Dis. 2019 Jun;19(6):561-562. doi: 10.1016/S1473-3099(19)30210-5. Epub 2019 Apr 29. No abstract available.

PMID:
31047851
13.

Antibiotic Resistance in Enterobacteriaceae from Surface Waters in Urban Brazil Highlights the Risks of Poor Sanitation.

Bartley PS, Domitrovic TN, Moretto VT, Santos CS, Ponce-Terashima R, Reis MG, Barbosa LM, Blanton RE, Bonomo RA, Perez F.

Am J Trop Med Hyg. 2019 Jun;100(6):1369-1377. doi: 10.4269/ajtmh.18-0726.

PMID:
30994094
14.

Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.

Jiao Y, Moya B, Chen MJ, Zavascki AP, Tsai H, Tao X, Sutaria DS, Louie A, Boyce JD, Deveson Lucas D, Kim TH, Tsuji BT, Bonomo RA, Drusano GL, Bulitta JB.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00425-19. doi: 10.1128/AAC.00425-19. Print 2019 Jul.

PMID:
30988147
15.

Polymyxins: To Combine or Not to Combine?

Perez F, El Chakhtoura NG, Yasmin M, Bonomo RA.

Antibiotics (Basel). 2019 Apr 10;8(2). pii: E38. doi: 10.3390/antibiotics8020038. Review.

16.

Reply to Humphrey and Spafford.

Bonomo RA, Evans SR.

Clin Infect Dis. 2019 Apr 6. pii: ciz228. doi: 10.1093/cid/ciz228. [Epub ahead of print] No abstract available.

PMID:
30953056
17.

Rapid Replacement of Acinetobacter baumannii Strains Accompanied by Changes in Lipooligosaccharide Loci and Resistance Gene Repertoire.

Adams MD, Wright MS, Karichu JK, Venepally P, Fouts DE, Chan AP, Richter SS, Jacobs MR, Bonomo RA.

MBio. 2019 Mar 26;10(2). pii: e00356-19. doi: 10.1128/mBio.00356-19.

18.

Epidemiology and genotypic characterisation of dissemination patterns of uropathogenic Escherichia coli in a community.

Matsukawa M, Igarashi M, Watanabe H, Qin L, Ohnishi M, Terajima J, Iyoda S, Morita-Ishihara T, Tateda K, Ishii Y, Saga T, Aoki K, Bonomo RA.

Epidemiol Infect. 2019 Jan;147:e148. doi: 10.1017/S0950268819000426.

19.

Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent.

Barnes MD, Kumar V, Bethel CR, Moussa SH, O'Donnell J, Rutter JD, Good CE, Hujer KM, Hujer AM, Marshall SH, Kreiswirth BN, Richter SS, Rather PN, Jacobs MR, Papp-Wallace KM, van den Akker F, Bonomo RA.

MBio. 2019 Mar 12;10(2). pii: e00159-19. doi: 10.1128/mBio.00159-19.

20.

Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

Papp-Wallace KM, Bethel CR, Caillon J, Barnes MD, Potel G, Bajaksouzian S, Rutter JD, Reghal A, Shapiro S, Taracila MA, Jacobs MR, Bonomo RA, Jacqueline C.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00105-19. doi: 10.1128/AAC.00105-19. Print 2019 May.

PMID:
30858223
21.

A Primer on AmpC Beta-Lactamases: Necessary Knowledge for an Increasingly Multidrug-Resistant World.

Tamma PD, Doi Y, Bonomo RA, Johnson JK, Simner PJ; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2019 Mar 6. pii: ciz173. doi: 10.1093/cid/ciz173. [Epub ahead of print]

PMID:
30838380
22.

Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases.

Degrossi JJ, Merino C, Isasmendi AM, Ibarra LM, Collins C, Bo NE, Papalia M, Fernandez JS, Hernandez CM, Papp-Wallace KM, Bonomo RA, Vazquez MS, Power P, Ramirez MS.

Curr Microbiol. 2019 Apr;76(4):485-494. doi: 10.1007/s00284-019-01653-4. Epub 2019 Feb 19.

PMID:
30783798
23.

Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect.

Ambrose PG, VanScoy BD, Luna BM, Yan J, Ulhaq A, Nielsen TB, Rudin S, Hujer K, Bonomo RA, Actis L, Skaar E, Spellberg B.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00112-19. doi: 10.1128/AAC.00112-19. Print 2019 May.

PMID:
30782989
24.

Shedding of methicillin-resistant Staphylococcus aureus by colonized patients during procedures and patient care activities.

Alhmidi H, Cadnum JL, Koganti S, Jencson AL, Rutter JD, Bonomo RA, Wilson BM, Mayer J, Samore MH, Donskey CJ.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):328-332. doi: 10.1017/ice.2018.342. Epub 2019 Feb 19.

PMID:
30777587
25.

The Clinical and Molecular Epidemiology of CTX-M-9 Group Producing Enterobacteriaceae Infections in Children.

Logan LK, Medernach RL, Domitrovic TN, Rispens JR, Hujer AM, Qureshi NK, Marshall SH, Nguyen DC, Rudin SD, Zheng X, Konda S, Weinstein RA, Bonomo RA.

Infect Dis Ther. 2019 Jun;8(2):243-254. doi: 10.1007/s40121-019-0237-2. Epub 2019 Feb 16.

26.

Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro.

Pandey R, Chen L, Manca C, Jenkins S, Glaser L, Vinnard C, Stone G, Lee J, Mathema B, Nuermberger EL, Bonomo RA, Kreiswirth BN.

MBio. 2019 Feb 12;10(1). pii: e02895-18. doi: 10.1128/mBio.02895-18.

27.

Antibiotic collateral sensitivity is contingent on the repeatability of evolution.

Nichol D, Rutter J, Bryant C, Hujer AM, Lek S, Adams MD, Jeavons P, Anderson ARA, Bonomo RA, Scott JG.

Nat Commun. 2019 Jan 18;10(1):334. doi: 10.1038/s41467-018-08098-6.

28.

The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

Luterbach CL, Boshe A, Henderson HI, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG Jr, Bonomo RA, van Duin D.

Open Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan.

29.

Interspecies DNA acquisition by a naturally competent Acinetobacter baumannii strain.

Traglia GM, Place K, Dotto C, Fernandez JS, Montaña S, Bahiense CDS, Soler-Bistue A, Iriarte A, Perez F, Tolmasky ME, Bonomo RA, Melano RG, Ramírez MS.

Int J Antimicrob Agents. 2019 Apr;53(4):483-490. doi: 10.1016/j.ijantimicag.2018.12.013. Epub 2019 Jan 3.

PMID:
30611868
30.

A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia in a Tertiary Care VA Medical Center.

Carr DR, Stiefel U, Bonomo RA, Burant CJ, Sims SV.

Open Forum Infect Dis. 2018 May 18;5(5):ofy089. doi: 10.1093/ofid/ofy089. eCollection 2018 May.

31.

1H, 13C, and 15N backbone resonance assignments for KPC-2, a class A serine-β-lactamase.

VanPelt J, Shurina BA, Ramelot TA, Bonomo RA, Page RC.

Biomol NMR Assign. 2019 Apr;13(1):139-142. doi: 10.1007/s12104-018-9866-8. Epub 2018 Dec 14.

PMID:
30552637
32.

Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.

Barnes MD, Taracila MA, Rutter JD, Bethel CR, Galdadas I, Hujer AM, Caselli E, Prati F, Dekker JP, Papp-Wallace KM, Haider S, Bonomo RA.

MBio. 2018 Dec 11;9(6). pii: e02085-18. doi: 10.1128/mBio.02085-18.

33.

Human fluids alter DNA-acquisition in Acinetobacter baumannii.

Martinez J, Liu C, Rodman N, Fernandez JS, Barberis C, Sieira R, Perez F, Bonomo RA, Ramirez MS.

Diagn Microbiol Infect Dis. 2019 Mar;93(3):183-187. doi: 10.1016/j.diagmicrobio.2018.10.010. Epub 2018 Oct 23.

PMID:
30420211
34.

Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS).

Evans SR, Follmann D, Liu Y, Holland T, Doernberg SB, Rouphael N, Hamasaki T, Jiang Y, Lok JJ, Tran TTT, Harris AD, Fowler VG, Boucher H, Kreiswirth BN, Bonomo RA, Van Duin D, Paterson DL, Chambers H.

Clin Infect Dis. 2019 May 17;68(11):1961-1967. doi: 10.1093/cid/ciy912.

PMID:
30351426
35.

The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.

Palacios AR, Mojica MF, Giannini E, Taracila MA, Bethel CR, Alzari PM, Otero LH, Klinke S, Llarrull LI, Bonomo RA, Vila AJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01754-18. doi: 10.1128/AAC.01754-18. Print 2019 Jan.

36.

ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases.

Jacobs MR, Abdelhamed AM, Good CE, Rhoads DD, Hujer KM, Hujer AM, Domitrovic TN, Rudin SD, Richter SS, van Duin D, Kreiswirth BN, Greco C, Fouts DE, Bonomo RA.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01801-18. doi: 10.1128/AAC.01801-18. Print 2019 Jan.

37.

New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections.

Isler B, Doi Y, Bonomo RA, Paterson DL.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01110-18. doi: 10.1128/AAC.01110-18. Print 2019 Jan. Review.

38.

Epidemiology of Carbapenem-Resistant Enterobacteriaceae at a Long-term Acute Care Hospital.

Chopra T, Rivard C, Awali RA, Krishna A, Bonomo RA, Perez F, Kaye KS.

Open Forum Infect Dis. 2018 Oct 3;5(10):ofy224. doi: 10.1093/ofid/ofy224. eCollection 2018 Oct.

39.

Human serum albumin alters specific genes that can play a role in survival and persistence in Acinetobacter baumannii.

Quinn B, Rodman N, Jara E, Fernandez JS, Martinez J, Traglia GM, Montaña S, Cantera V, Place K, Bonomo RA, Iriarte A, Ramírez MS.

Sci Rep. 2018 Oct 3;8(1):14741. doi: 10.1038/s41598-018-33072-z.

40.

Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children.

Logan LK, Medernach RL, Rispens JR, Marshall SH, Hujer AM, Domitrovic TN, Rudin SD, Zheng X, Qureshi NK, Konda S, Hayden MK, Weinstein RA, Bonomo RA.

Pediatr Infect Dis J. 2019 Jun;38(6):595-599. doi: 10.1097/INF.0000000000002205.

PMID:
30281548
41.

Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV.

Evans SR, Tran TTT, Hujer AM, Hill CB, Hujer KM, Mediavilla JR, Manca C, Domitrovic TN, Perez F, Farmer M, Pitzer KM, Wilson BM, Kreiswirth BN, Patel R, Jacobs MR, Chen L, Fowler VG, Chambers HF, Bonomo RA; Antibacterial Resistance Leadership Group (ARLG).

Clin Infect Dis. 2019 May 17;68(11):1823-1830. doi: 10.1093/cid/ciy801.

PMID:
30239599
42.

Acinetobacter nosocomialis: Defining the Role of Efflux Pumps in Resistance to Antimicrobial Therapy, Surface Motility, and Biofilm Formation.

Knight DB, Rudin SD, Bonomo RA, Rather PN.

Front Microbiol. 2018 Aug 21;9:1902. doi: 10.3389/fmicb.2018.01902. eCollection 2018.

43.

A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults.

Logan LK, Nguyen DC, Scaggs Huang FA, Qureshi NK, Charnot-Katsikas A, Bartlett AH, Zheng X, Hujer AM, Domitrovic TN, Marshall SH, Bonomo RA, Weinstein RA.

Pediatr Infect Dis J. 2019 May;38(5):490-495. doi: 10.1097/INF.0000000000002176.

PMID:
30169484
44.

Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistance.

Galdadas I, Lovera S, Pérez-Hernández G, Barnes MD, Healy J, Afsharikho H, Woodford N, Bonomo RA, Gervasio FL, Haider S.

Sci Rep. 2018 Aug 27;8(1):12916. doi: 10.1038/s41598-018-31176-0.

45.

A Noncanonical Metal Center Drives the Activity of the Sediminispirochaeta smaragdinae Metallo-β-lactamase SPS-1.

Cheng Z, VanPelt J, Bergstrom A, Bethel C, Katko A, Miller C, Mason K, Cumming E, Zhang H, Kimble RL, Fullington S, Bretz SL, Nix JC, Bonomo RA, Tierney DL, Page RC, Crowder MW.

Biochemistry. 2018 Sep 4;57(35):5218-5229. doi: 10.1021/acs.biochem.8b00728. Epub 2018 Aug 21.

46.

Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection.

Dousa KM, Babiker A, Van Aartsen D, Shah N, Bonomo RA, Johnson JL, Skalweit MJ.

Open Forum Infect Dis. 2018 Jul 18;5(7):ofy168. doi: 10.1093/ofid/ofy168. eCollection 2018 Jul.

47.

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations.

Pogue JM, Bonomo RA, Kaye KS.

Clin Infect Dis. 2019 Jan 18;68(3):519-524. doi: 10.1093/cid/ciy576.

PMID:
30020449
48.

Correction to Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.

Chen AY, Thomas PW, Stewart AC, Bergstrom A, Cheng Z, Miller C, Bethel CR, Marshall SH, Credille CV, Riley CL, Page RC, Bonomo RA, Crowder MW, Tierney DL, Fast W, Cohen SM.

J Med Chem. 2018 Jul 26;61(14):6400. doi: 10.1021/acs.jmedchem.8b01057. Epub 2018 Jul 18. No abstract available.

PMID:
30019584
49.

Emergence of Resistance to Colistin During the Treatment of Bloodstream Infection Caused by Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae.

Kanwar A, Marshall SH, Perez F, Tomas M, Jacobs MR, Hujer AM, Domitrovic TN, Rudin SD, Rojas LJ, Kreiswirth BN, Chen L, Quinones-Mateu M, van Duin D, Bonomo RA; Antibacterial Resistance Leadership Group.

Open Forum Infect Dis. 2018 Apr 23;5(4):ofy054. doi: 10.1093/ofid/ofy054. eCollection 2018 Apr.

50.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

Russo A, Falcone M, Gutiérrez-Gutiérrez B, Calbo E, Almirante B, Viale PL, Oliver A, Ruiz-Garbajosa P, Gasch O, Gozalo M, Pitout J, Akova M, Peña C, Cisneros JM, Hernández-Torres A, Farcomeni A, Prim N, Origüen J, Bou G, Tacconelli E, Tumbarello M, Hamprecht A, Karaiskos I, de la Calle C, Pérez F, Schwaber MJ, Bermejo J, Lowman W, Hsueh PR, Mora-Rillo M, Rodriguez-Gomez J, Souli M, Bonomo RA, Paterson DL, Carmeli Y, Pascual A, Rodríguez-Baño J, Venditti M; REIPI/ESGBIS/INCREMENT investigators.

Int J Antimicrob Agents. 2018 Nov;52(5):577-585. doi: 10.1016/j.ijantimicag.2018.06.018. Epub 2018 Jun 30.

PMID:
29969692

Supplemental Content

Loading ...
Support Center